Results (3967)
A multi-site observational study to assess safety and effectiveness of prenatal exposure to Dolutegravir in pregnant individuals living with HIV (212976)
United States
EU PAS number:
EUPAS32268
First published:
25/04/2024
StudyFinalised
XEVUDY General Drug Use Investigation (SARS-CoV-2 Infection) - COVID-19 (217893)
Japan
EU PAS number:
EUPAS103974
First published:
25/04/2024
StudyFinalised
Prevention of gastric cancer by eradication of Helicobacter pylori infection
Slovenia
EU PAS number:
EUPAS107327
First published:
25/04/2024
StudyOngoing
A post-authorisation safety study (PASS) to describe real-world safety and effectiveness of NUCALA (mepolizumab) in paediatric eosinophilic granulomatosis with polyangiitis (EGPA) patients in Europe (218065)
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS49460
First published:
25/04/2024
StudyPlanned
115056 - A prospective study to evaluate the safety, effectiveness and impact of the RTS, S/AS01E vaccine in young children in sub-Saharan Africa (EPI-MALARIA-003 VS AME)
Ghana
Kenya
Malawi
EU PAS number:
EUPAS28541
First published:
25/04/2024
StudyOngoing
Study of Vaccine Efficacy in Health Care Workers (PSVEHCW)
Albania
Belgium
France
Lithuania
Portugal
Romania
Spain
EU PAS number:
EUPAS39736
First published:
25/04/2024
StudyPlanned
Post-authorization Safety Study: Ponesimod Pregnancy Outcomes Program Utilizing Enhanced Pharmacovigilance Monitoring (POEM)
Austria
Belgium
Bulgaria
Canada
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS50031
First published:
25/04/2024
StudyOngoing
TREAT NL/BE registry (TREatment of Atopic eczema, the Netherlands and Belgium)
Belgium
Netherlands
First published:
24/04/2024
Data source
Disease registryNon-Interventional Post-Authorisation Study to Evaluate the Safety, Tolerability and Effectiveness of Berotralstat for Patients with Hereditary Angioedema (HAE) in a Real-World Setting (APeX-N)
Australia
France
Germany
Norway
Sweden
United Kingdom
EU PAS number:
EUPAS43575
First published:
24/04/2024
StudyPlanned
WAYLIVRA® Post-Authorisation Safety Study (PASS) and Product Registry (WAYLIVRA PASS)
Austria
France
Germany
Greece
Italy
Netherlands
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS36702
First published:
23/04/2024
StudyOngoing
Use cases for development, optimisation and implementation of artificial intelligence methods for real world data analyses in regulatory decision-making and health technology assessment along the product lifecycle (Real4Reg)
Denmark
Finland
Germany
Portugal
EU PAS number:
EUPAS105544
First published:
23/04/2024
StudyOngoing
An observational study describing the effectiveness and safety of BLINCYTO® in Chinese adults with Philadelphia chromosome-positive relapsed or refractory B-cell precursor Acute Lymphoblastic Leukemia (Ph+ R/R B-cell precursor ALL) (20210061)
China
EU PAS number:
EUPAS107858
First published:
23/04/2024
StudyOngoing
Pharmacoepidemiology Research, Federal Institute for Drugs and Medical Devices (BfArM)
Germany
First published:
23/04/2024
Institution
Regulatory AuthorityENCePP partnerDanny Platform
Bulgaria
Croatia
Romania
Serbia
Slovenia
First published:
23/04/2024
Data source
Hospital inpatient recordsOtherPrimary care medical recordsCentre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)
Sweden
First published:
23/04/2024
Institution
Educational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partneraggregate Gargano Mortality Study
Italy
First published:
23/04/2024
Data source
Hospital inpatient recordsThe Valencia Health System Integrated Database
Spain
First published:
23/04/2024
Data source
Hospital outpatient visit recordsOtherPrimary care medical recordsRegistration with healthcare systemHospital Vall d'Hebron
Spain
First published:
23/04/2024
Data source
Hospital discharge recordsHospital outpatient visit recordsOtherIMI 116026 HARMONY; IMI 945406 HARMONY PLUS - HARMONY Big Data Platform
Austria
Belgium
Brazil
Canada
Denmark
France
Germany
Greece
Italy
Kuwait
Netherlands
Poland
Qatar
Singapore
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United Kingdom (Northern Ireland)
First published:
23/04/2024
Data source
Cancer registryOtherRegistration with healthcare systemEUROmediCAT central database
Belgium
Croatia
Denmark
France
Germany
Ireland
Italy
Malta
Netherlands
Norway
Poland
Spain
Switzerland
First published:
23/04/2024
Data source
Disease registryGerman Atopic Dermatitis Registry TREATgermany
Germany
First published:
23/04/2024
Data source
Disease registryPrimary care medical recordsGlobal Fukutin-Related Protein Registry
Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
First published:
23/04/2024
Data source
Disease registryThe European HBV Registry - A joint initiative of TherVacB and DZIF
Germany
Italy
Spain
First published:
23/04/2024
Data source
Disease registryMS-Register of the National MS-Society of Germany (DMSG, Bundesverband e.V.)
Germany
First published:
23/04/2024
Data source
Disease registryPrimary care medical recordsSpontaneous reporting of adverse drug reactionsEuropean Porphyria Registry
Belgium
France
Italy
Netherlands
Norway
Spain
Sweden
United Kingdom
First published:
23/04/2024
Data source
Disease registryEuropean Network and Registry for Homocystinurias and Methylation Defects - E-HOD
Austria
Belgium
Brazil
Colombia
Croatia
Czechia
Denmark
France
Germany
Greece
Hungary
Iran, Islamic Republic of
Ireland
Italy
Netherlands
Poland
Portugal
Spain
Switzerland
Taiwan
United Kingdom
United States
First published:
23/04/2024
Data source
Disease registryOtherEuropean registry and network for intoxication type metabolic diseases
Austria
Belgium
Croatia
Czechia
Denmark
France
Germany
Hungary
Italy
Netherlands
Poland
Portugal
Spain
Switzerland
Taiwan
United Kingdom
United States
First published:
23/04/2024
Data source
Disease registryOtherMyotubular and Centronuclear Myopathy Patient Registry
United Kingdom
First published:
23/04/2024
Data source
Disease registryRheumatoid Arthritis - Observation of Biologic Therapies
Germany
First published:
23/04/2024
Data source
Disease registryDutch Keratinocyte Cancer Collaborative
Netherlands
First published:
23/04/2024
Data source
Administrative healthcare claimsDisease registryOtherERN RARE-LIVER prospective research registry
Argentina
Belgium
Canada
Czechia
Denmark
Germany
Greece
Hungary
Israel
Italy
Lithuania
Netherlands
Poland
Slovakia
Spain
Switzerland
United Kingdom
First published:
23/04/2024
Data source
Disease registryOtherThe United Kingdom Facioscapulohumeral Dystrophy Patient Registry
Ireland
United Kingdom
First published:
23/04/2024
Data source
Disease registryThe United Kingdom National Registry for Myotonic Dystrophy
Ireland
United Kingdom
First published:
23/04/2024
Data source
Disease registryEnroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort A CHDI Foundation Project
Argentina
Australia
Austria
Belgium
Canada
Chile
Colombia
Czechia
Denmark
France
Germany
Ireland
Italy
Netherlands
New Zealand
Norway
Peru
Poland
Portugal
Spain
Switzerland
United Kingdom
United States
First published:
23/04/2024
Data source
BiobankDisease registryAdvancing the Patient Experience in Chronic Obstructive Pulmonary Disease (COPD) Registry
United States
First published:
23/04/2024
Data source
Disease registryOtherPrimary care medical recordsInternational Severe Asthma Registry
Argentina
Australia
Bulgaria
Canada
Colombia
Denmark
Estonia
Germany
Greece
Hungary
India
Ireland
Italy
Japan
Kuwait
Mexico
Poland
Portugal
Saudi Arabia
Singapore
Sweden
Taiwan
United Arab Emirates
United Kingdom
United States
First published:
23/04/2024
Data source
Disease registryREGISTRY: a study by the European Huntington’s Disease Network
Austria
Belgium
Czechia
Denmark
Finland
France
Germany
Italy
Netherlands
Norway
Poland
Portugal
Russian Federation
Slovenia
Sweden
Switzerland
United Kingdom
First published:
23/04/2024
Data source
BiobankDisease registryGerman Pharmacoepidemiological Research Database
Germany
First published:
23/04/2024
Data source
Administrative healthcare claims